🇺🇸 FDA
Patent

US 9382213

Heterocyclic and cyclic analogs of propargyl-linked inhibitors of dihydrofolate reductase

granted A61KA61K31/505

Quick answer

US patent 9382213 (Heterocyclic and cyclic analogs of propargyl-linked inhibitors of dihydrofolate reductase) held by UNIVERSITY OF CONNECTICUT expires Mon Jun 30 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
UNIVERSITY OF CONNECTICUT
Grant date
Tue Jul 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 30 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K31/505